Dimethylamine → (R)-1-(2-(2-Cyclopropylpyrimidin-4-yl)-3H-imidazo[4,5-b]pyridin-5-yl)-N,N-dimethylpiperidine-3-carboxamide
反応式
[CH3:1][NH:2][CH3:3].C(N(CC)CC)C.[CH:11]1([C:14]2[N:19]=[C:18]([C:20]3[NH:37][C:23]4=[N:24][C:25]([N:28]5[CH2:33][CH2:32][CH2:31][C@@H:30]([C:34](O)=[O:35])[CH2:29]5)=[CH:26][CH:27]=[C:22]4[N:21]=3)[CH:17]=[CH:16][N:15]=2)[CH2:13][CH2:12]1.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1>CN(C)C=O>[CH:11]1([C:14]2[N:19]=[C:18]([C:20]3[NH:37][C:23]4=[N:24][C:25]([N:28]5[CH2:33][CH2:32][CH2:31][C@@H:30]([C:34]([N:2]([CH3:3])[CH3:1])=[O:35])[CH2:29]5)=[CH:26][CH:27]=[C:22]4[N:21]=3)[CH:17]=[CH:16][N:15]=2)[CH2:13][CH2:12]1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 50 °C
実験手順
To a solution of dimethylamine (175 μmol) in N,N-dimethylformamide (200 μL) was added triethylamine (35 μL, 250 μmol) and (R)-1-(2-(2-cyclopropylpyrimidin-4-yl)-3H-imidazo[4,5-b]pyridin-5-yl)piperidine-3-carboxylic acid (200 μL, 50 μmol, 0.25M in N,N-dimethylformamide) followed by 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (250 μL, 100 μmol, 0.4M in N,N-dimethylformamide). The reaction mixture was stirred at 50° C. for 16 h. The solvent was removed by Speedvac and the residue was purified via HPLC to afford the title compound. MS API-ES+ (M+H) 392; HPLC retention time 2.43 min (Method C).
後処理
- customThe solvent was removed by Speedvac
- customthe residue was purified via HPLC
出典と根拠
- ORDレコード
- ord-2e9914e33760482eae70801b85798f19
- 出典データセット
- uspto-grants-2016_03
- 特許番号
- US09296745B2
反応ノート
読み込み中…